Sangamo Therapeutics Announces Fourth Quarter and Full Year 2018 Conference Call and Webcast

BRISBANE, Calif., Feb. 21, 2019  /PRNewswire/ -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the Company will release its fourth quarter and full year 2018 financial results after the market closes on Thursday, February 28, 2019. The press release will be followed by a conference call at 5:00 p.m. ET, which will be open to the public via telephone and webcast. During the conference call, the Company will review its financial results and provide a business update.

The conference call dial-in numbers are [phone] for domestic callers and [phone] for international callers. The conference ID number for the call is 6875578. Participants may access the live webcast via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. A conference call replay will be available for one week following the conference call. The conference call replay numbers for domestic and international callers are [phone] and [phone], respectively. The conference ID number for the replay is 6875578.

About Sangamo Therapeutics
Sangamo Therapeutics, Inc. is focused on translating ground-breaking science into genomic medicines with the potential to transform patients' lives using the Company's platform technologies in genome editing, gene therapy, gene regulation and cell therapy. For more information about Sangamo, visit www.sangamo.com.

 

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/sangamo-therapeutics-announces-fourth-quarter-and-full-year-2018-conference-call-and-webcast-300799927.html

SOURCE Sangamo Therapeutics, Inc.

Copyright 2019 PR Newswire